DETAILED NOTES ON CLONAZOLAM

It was developed while in the Soviet Union from the nineteen seventies. It had been claimed by its developers that its rewards above other nitrosoureas are a relatively reduced hematological toxicity in addition to a broader therapeutic index, which allows for its outpatient administration.Organ harm: Extended use may bring about liver and kidney i